Management of Stage I Testicular Cancer

Jerusha Padayachee; Roderick Clark; Padraig Warde; Robert J. Hamilton

Disclosures

Curr Opin Urol. 2022;32(1):17-23. 

In This Article

Conclusion

Our approach at Princess Margaret Cancer Centre is to adopt one of active surveillance for both CSI seminoma and NSGCTs, irrespective of risk profile; and following patient consultation. As highlighted here, such an approach with a dedicated surveillance program, better selects for patients who truly require additional treatments postorchiectomy, and spares a significant proportion the early and late toxicities of adjuvant chemotherapy and radiotherapy, without compromise to survival outcomes.

processing....